Funding for Medical Research
and Clinical Trials
and Clinical Trials
Funding Details for Cancer
Use the contact information shown for the organization to apply for the funding.
Please notify CenTrial of any offer is incorrect or has expired.
Please notify CenTrial of any offer is incorrect or has expired.
Immunotherapy Resistance in Lung Cancer
LUNGevity Foundation
Type of Organization: Foundation
Contact Name: Jody Roosevelt
Email Address: jroosevelt@LUNGevity.org
Funds Available for Clinical Trials: ✗ Research: ✔
At the start of the award term, the applicant, who must be a principal investigator for the proposed research, must: 1) hold a doctoral degree and faculty appointment (or equivalent) with an academic institution, including research institutions that are not formally associated with a university 2) have completed a postdoctoral training fellowship. An applicant may be at any level of research experience and must be an independent, selfdirected researcher for whom their institution must provide space and other resources customary for independent investigators. The application must convey the commitment of the institution to the applicant and the proposed research activities. An applicant with an existing LUNGevity award (except a Career Development Award) may apply. Team Preference: While not a requirement, we encourage a team approach with the inclusion of at least two institutions right from the LOI stage. One institution may serve as the primary institution. Please reach out to us if you have any questions about the team preference. Geographical Restriction: International teams are highly recommended. The award program does not have any geographical restrictions. Applicants are not required to be U.S. citizens or to be employed by a U.S. institution. At the time of application, if an applicant is employed by a U.S. institution, they must be a United States citizen or a foreign national holding one of the following visa immigration statuses: permanent resident (Green Card), exchange visitor (J-1), temporary worker in a specialty occupation (H-1, H-1B), Canadian or Mexican citizen engaging in professional activities (TC or TN), or temporary worker with extraordinary abilities in the sciences (O-1).
The application must be submitted in English.
Other info: The Brown/LUNGevity Award to Understand Mechanisms of Resistance to Immunotherapy will fund high-impact research that seeks to understand resistance to first-line immunotherapy and develop therapeutic strategies targeting this resistance. The program has no geographical restrictions and is open to both US and non-US applicants.
Applications Open Early Next Year.
LUNGevity Foundation
Type of Organization: Foundation
Contact Name: Jody Roosevelt
Email Address: jroosevelt@LUNGevity.org
Funds Available for Clinical Trials: ✗ Research: ✔
Funding Details
Requirements: Education and Experience:At the start of the award term, the applicant, who must be a principal investigator for the proposed research, must: 1) hold a doctoral degree and faculty appointment (or equivalent) with an academic institution, including research institutions that are not formally associated with a university 2) have completed a postdoctoral training fellowship. An applicant may be at any level of research experience and must be an independent, selfdirected researcher for whom their institution must provide space and other resources customary for independent investigators. The application must convey the commitment of the institution to the applicant and the proposed research activities. An applicant with an existing LUNGevity award (except a Career Development Award) may apply. Team Preference: While not a requirement, we encourage a team approach with the inclusion of at least two institutions right from the LOI stage. One institution may serve as the primary institution. Please reach out to us if you have any questions about the team preference. Geographical Restriction: International teams are highly recommended. The award program does not have any geographical restrictions. Applicants are not required to be U.S. citizens or to be employed by a U.S. institution. At the time of application, if an applicant is employed by a U.S. institution, they must be a United States citizen or a foreign national holding one of the following visa immigration statuses: permanent resident (Green Card), exchange visitor (J-1), temporary worker in a specialty occupation (H-1, H-1B), Canadian or Mexican citizen engaging in professional activities (TC or TN), or temporary worker with extraordinary abilities in the sciences (O-1).
The application must be submitted in English.
Other info: The Brown/LUNGevity Award to Understand Mechanisms of Resistance to Immunotherapy will fund high-impact research that seeks to understand resistance to first-line immunotherapy and develop therapeutic strategies targeting this resistance. The program has no geographical restrictions and is open to both US and non-US applicants.
Applications Open Early Next Year.